Related Experiment Video
Updated: Jul 16, 2026

07:59
Bioluminescence Imaging to Detect Late Stage Infection of African Trypanosomiasis
Published on: May 18, 2016
8.2K
Product Development Partnerships: Delivering Innovation for the Elimination of African Trypanosomiasis?
Emma Michelle Taylor1, James Smith2
1Department of Social Anthropology, University of Edinburgh, Edinburgh, EH8 9LD, UK.
Tropical Medicine and Infectious Disease
|January 19, 2020
Summary
Product Development Partnerships (PDPs) have been crucial in developing new tools for controlling African trypanosomiasis. These organizations successfully delivered innovations in diagnostics and treatments, highlighting their vital role in disease control.
Area of Science:
- Neglected tropical diseases
- Global health innovation
- Parasitic disease research
Background:
- African trypanosomiasis, also known as sleeping sickness, is a 'tool-deficient' disease.
- Limited innovations exist for its control and elimination.
- Product Development Partnerships (PDPs) aim to address this gap.
Purpose of the Study:
- To evaluate the role of PDPs in delivering new tools for African trypanosomiasis.
- To understand the mechanisms used by PDPs to foster innovation.
- To assess the impact of PDPs on disease control efforts.
Main Methods:
- Analysis of three PDPs: DNDi, FIND, and GALVmed.
- Focus on drugs, diagnostics, and animal health innovations.
- Key informant interviews within each organization.
Main Results:
- PDPs have delivered new innovations for diagnosis and treatment.
- They successfully brokered innovation and private sector involvement.
- These innovations likely would not have emerged without PDPs.
Conclusions:
- PDPs play a significant role in delivering health innovations.
- PDPs are shifting towards a greater brokering role, influenced by donors.
- Donors should optimize incentives for PDPs to ensure continued product delivery.
Related Concept Videos
Production of Biopesticides
Biopesticides offer a sustainable alternative to chemical pesticides, utilizing microbial agents to control agricultural pests. Bacillus thuringiensis (Bt) is a widely employed bacterium known for its potent insecticidal activity. Bt biopesticides are favored for their specificity to insect pests, minimal environmental impact, and natural degradability.Mechanism of Bt Toxin Action Bt produces insecticidal crystal (Cry) proteins during its sporulation phase. These proteins form parasporal...
Leishmaniasis
Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
American Trypanosomiasis
Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...

